Evaluating the LibAirty Airway Clearance System for Adults with Bronchiectasis at Home Over 12 Months

What this Trial Is About

This research aims to evaluate how adults with bronchiectasis use the LibAirty132 Airway Clearance System at home and how it affects their lung symptoms and healthcare needs. The study focuses on measuring how often participants experience flare-ups of their lung condition, called pulmonary exacerbations, while using the device over a 12-month period. The study is observational and collects real-world data without changing participants standard treatments. Participants have been prescribed the LibAirty132 system by their doctors as part of their usual care and continue using it at home as directed. The study does not provide the device nor assign its use. Over the 12 months, data will be gathered during up to four regular clinic visits, including questionnaires about symptoms and device satisfaction, medical record reviews, and device usage logs to track adherence. During these visits, researchers will also monitor hospital stays, emergency room visits, antibiotic use, lung function tests, quality of life changes, and healthcare resource use related to bronchiectasis. Participants will maintain their normal clinic appointments and treatment plans throughout the study. The total participation time is 12 months from when individuals begin using the LibAirty132 system at home.

Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS)